Search Results

Biotech Bay

Episona Enters Consumer Market with Epigenetics Test for Male Infertility

Episona announced today that it is entering the consumer market with the first at-home, epigenetics-based test for evaluating male infertility.

October 18, 2017

·

4 min read

Biotech Bay

Episona Launches International Sales of Epigenetic Test for Male Infertility

Episona announced today that it has expanded online sales of Seed, its at-home test for evaluating male infertility and poor embryo development, to consumers globally, with a few exceptions such as China.

October 30, 2017

·

2 min read

Biotech Bay

Episona Presents Data on Sperm DNA Methylation Patterns at ASRM Congress Expo

Episona announced data of a prospective, controlled, multi-institutional clinical trial of 210 patients which appears to illustrate emerging and robust relationships between sperm DMPs and abnormal semen parameters among infertile couples.

October 30, 2017

·

2 min read

Business

Episona Appoints Vice President Of Sales

August 15, 2017

·

3 min read

BioMidwest

Episona Launches First Epigenetic Test For Predicting Male Infertility And Embryo Quality

October 17, 2016

·

4 min read

Business

Episona Raises $4 Million Seed Round For Commercial Expansion Of Epigenetics Test For Male Infertility And Poor Embryo Quality

June 6, 2017

·

3 min read

Biotech Beach

Sperm Test 2.0: New Diagnostics Aim To Better Understand Male Infertility, Episona Reveals

October 17, 2016

·

1 min read

Male Infertility Market Growing at 6.2% CAGR during (2020-2027) to Reach USD 6.21 Billion | The Insight Partners

The Insight Partners published latest research report on “Male Infertility Market Size Report, Share, Trends, Growth & Key Companies Forecast to 2027 - COVID-19 Impact and Global Analysis by Test; Treatment Type; Distribution Channel

May 11, 2023

·

6 min read